Milestone Pharmaceuticals Inc

Milestone Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. The company's lead product candidate consists of MSP-2017, a nasal spray. Milestone Pharmaceuticals Inc. is based in Montr'al, Canada.

Address Details

Address: 1111 DR. FREDERIK-PHILIPS BOULEVARD SUITE 420

City: MONTREAL

State: A8

Country: CAN

Zip Code: H4M 2X6